| Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans L Che, W Chi, Y Qiao, J Zhang, X Song, Y Liu, L Li, J Jia, MG Pilo, J Wang, ... Gut 69 (1), 177-186, 2020 | 152 | 2020 |
| Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice J Wang, M Dong, Z Xu, X Song, S Zhang, YU Qiao, L Che, J Gordan, K Hu, ... Oncogene 37 (24), 3229-3242, 2018 | 97 | 2018 |
| Glucose catabolism in liver tumors induced by c-MYC can be sustained by various PKM1/PKM2 ratios and pyruvate kinase activities A Méndez-Lucas, X Li, J Hu, L Che, X Song, J Jia, J Wang, C Xie, ... Cancer research 77 (16), 4355-4364, 2017 | 79 | 2017 |
| Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma R Shang, X Song, P Wang, Y Zhou, X Lu, J Wang, M Xu, X Chen, ... Gut 70 (9), 1746-1757, 2021 | 74 | 2021 |
| Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma X Song, X Liu, H Wang, J Wang, Y Qiao, A Cigliano, K Utpatel, S Ribback, ... Clinical Cancer Research 25 (1), 403-413, 2019 | 67 | 2019 |
| A human multi-lineage hepatic organoid model for liver fibrosis Y Guan, A Enejder, M Wang, Z Fang, L Cui, SY Chen, J Wang, Y Tan, ... Nature communications 12 (1), 6138, 2021 | 64 | 2021 |
| Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation X Song, H Xu, P Wang, J Wang, S Affo, H Wang, M Xu, B Liang, L Che, ... Journal of hepatology 75 (4), 888-899, 2021 | 52 | 2021 |
| Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis S Mancarella, G Serino, F Dituri, A Cigliano, S Ribback, J Wang, X Chen, ... Cell Death & Differentiation 27 (8), 2330-2343, 2020 | 52 | 2020 |
| Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis J Wang, H Wang, M Peters, N Ding, S Ribback, K Utpatel, A Cigliano, ... Journal of hepatology 71 (4), 742-752, 2019 | 52 | 2019 |
| Axis inhibition protein 1 (Axin1) deletion–induced hepatocarcinogenesis requires intact β‐catenin but not notch cascade in mice Y Qiao, J Wang, E Karagoz, B Liang, X Song, R Shang, K Evert, M Xu, ... Hepatology 70 (6), 2003-2017, 2019 | 42 | 2019 |
| TAZ is indispensable for c-MYC-induced hepatocarcinogenesis H Wang, S Zhang, Y Zhang, J Jia, J Wang, X Liu, J Zhang, X Song, ... Journal of hepatology 76 (1), 123-134, 2022 | 35 | 2022 |
| Hippo cascade controls lineage commitment of liver tumors in mice and humans XC Shanshan Zhang, Jingxiao Wang, Haichuan Wang, Lingling Fan, Biao Fan ... American Journal of Pathology, 2018 | 32 | 2018 |
| Role of the Notch signaling in cholangiocarcinoma A Cigliano, J Wang, X Chen, DF Calvisi Expert opinion on therapeutic targets 21 (5), 471-483, 2017 | 32 | 2017 |
| TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis B Liang, Y Zhou, M Qian, M Xu, J Wang, Y Zhang, X Song, H Wang, S Lin, ... Journal of hepatology 75 (1), 120-131, 2021 | 29 | 2021 |
| Distinct and overlapping roles of hippo effectors YAP and TAZ during human and mouse hepatocarcinogenesis H Wang, J Wang, S Zhang, J Jia, X Liu, J Zhang, P Wang, X Song, L Che, ... Cellular and molecular gastroenterology and hepatology 11 (4), 1095-1117, 2021 | 28 | 2021 |
| Oncogene-dependent function of BRG1 in hepatocarcinogenesis P Wang, X Song, D Cao, K Cui, J Wang, K Utpatel, R Shang, H Wang, ... Cell death & disease 11 (2), 91, 2020 | 27 | 2020 |
| Functional role of SGK3 in PI3K/Pten driven liver tumor development H Cao, Z Xu, J Wang, A Cigliano, MG Pilo, S Ribback, S Zhang, Y Qiao, ... BMC cancer 19, 1-13, 2019 | 21 | 2019 |
| β-Catenin sustains and is required for YES-associated protein oncogenic activity in cholangiocarcinoma Y Zhang, H Xu, G Cui, B Liang, X Chen, S Ko, S Affo, X Song, Y Liao, ... Gastroenterology 163 (2), 481-494, 2022 | 18 | 2022 |
| Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models J Wang, X Yang, H Han, L Wang, W Bao, S Wang, RM Hoffman, M Yang, ... Chinese Journal of Cancer Research 30 (1), 112, 2018 | 15 | 2018 |
| The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease A Cigliano, S Zhang, S Ribback, S Steinmann, M Sini, CE Ament, ... Journal of Experimental & Clinical Cancer Research 41 (1), 192, 2022 | 14 | 2022 |
